 NEW YORK, Jan. 03, 2023 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq: ITCI, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system CNS disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. PT. 